Atipamezole is a synthetic α2 adrenoceptor antagonistused to reverse the sedative and analgesic effects of dexmedetomidine and medetomidine in dogs. It has also been undergone research as a potential anti-Parkinsonian drug for humans.
For the reversal of the sedative and analgesic effects of dexmedetomidine and medetomidine in dogs.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.